How AI is Transforming Drug Development: Reflections from AAPS - PharmSci 360 with Mark Arnold
Description
Dr. Mark Arnold, a distinguished bioanalytical thought leader with an impressive track record in supporting drug development programs. Mark is the Owner and Principal at Bioanalytical Solution Integration, where he provides strategic counsel on complex bioanalytical assays and regulatory compliance. With over 35 years of experience, including leadership roles at BMS and Labcorp, Mark has become a key figure in the biotech and pharma industries. He is also an AAPS Fellow and a founder of the Global Bioanalysis Consortium.
01:05 - Career Reflections and Contributions to Drug Development
05:28 - Understanding the Integration of Drug Development
09:30 - What Would You Change? Embracing Career Risks in Pharma
11:32 - Navigating Career Paths: Small vs. Large Companies
16:09 - NEW NEWS! - Can Electrical Fields Disrupt Cancer?
23:28 - The Role of AI in Drug Development
31:13 - Encouraging Innovation in a Regulated Industry
Follow Mark, Chad and Gregory:
Please donate to: Samaritan’s Purse
https://www.samaritanspurse.org/
Mark Arnold - https://www.linkedin.com/in/markearnoldphd/
Blog - https://bioanalysisandbiomarkers.blogspot.com/
Dr. Chad Briscoe - https://www.linkedin.com/in/chadbriscoe/
Celerion - https://www.celerion.com/
Gregory Austin - https://www.linkedin.com/in/gregoryaustin1/
ECI - https://eci-rx.com /
BioTalk Unzipped on LinkedIn - https://www.linkedin.com/company/biotalk-unzipped/
New News Story:
Novocure wins FDA approval for electric field device in lung cancer
Two articles on finding 1000’s of dark matter RNA viruses:
Image Credits
Novocure images courtesy of Novocure: www.novocure.com
United States
